Upbeat earnings lifted the market during the midday with the Dow rising 7 points to 15,283. Nasdaq rose 6 points to 3477.
On the upside
Eagle Bulk Shipping (Nasdaq: EGLE) reversed year ago losses to post a profit for the first quarter as revenue climbed.
Shares of National Bank of Greece (NYSE: NBG) climbed for the fourth day in a row despite a lack of news.
Halozyme Therapeutics (Nasdaq: HALO) expects to present positive data from a Phase 1b study of its pancreatic cancer treatment PEGPH20 at the 2013 American Society of Clinical Oncology Annual Meeting.
On the downside
Infinity Pharmaceuticals (Nasdaq: INFI) will present clinical trial data for its IPI-145 at two upcoming conferences.
Oncothyreon (Nasdaq: ONTY) reported disappointing results from a Phase III START trial of its lung cancer treatment L-BLP25.
Cyclacel Pharmaceuticals (Nasdaq: CYCC) priced its public offering of approximately 6.67 million common shares at the discounted price of $3.00 per share.
In the broad market, declining issues outpaced advancers by a margin of more than 10 to 9 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 index eased a point to 1657.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here